Share
Journal Information
Special content about coronavirus SARS-CoV-2 (COVID-19) in Nefrología (English Edition)
The effect of pentoxifylline on reduction of proteinuria among patients with type 2 diabetes under blockade of angiotensin system: a double blind and randomized clinical trial
Ali Ghorbani, Ali Ghorbani, Bita Omidvar, Bita Omidvar, Seyed S. Beladi-Mousavi, Seyed Seifollah Beladi Mousavi, Elena Lak, Elena Lak, Sima Vaziri, Sima Vaziri
10.3265/Nefrologia.pre2012.Jun.11242
Nefrologia (English Version) 2012;32:790-6
About the discrepancies between consensus documents, clinical practice guidelines, and legal regulations in the treatment of type 2 diabetes
* GEENDIAB (Grupo español para el estudio de la nefropatía diabética) y REDINREN (Red de Investigacion Renal)., Alberto Martínez-Castelao*, José L. Górriz*, Eva Sola, Carlos Morillas, Ana Jover, Francisco Coronel, Juan Navarro-González*, Fernando De Álvaro*
10.3265/Nefrologia.pre2012.Jun.11576
Nefrologia (English Version) 2012;32:419-26
Discrepancies among consensus documents, guidelines, clinical practice and the legal framework for the treatment of type 2 diabetes mellitus patients
endocrinología y atención primaria de Alcoy Nefrología, endocrinología y atención primaria de Alcoy, Endocrinología y Atención Primaria de Alcoy Nefrología, Endocrinología y Atención Primaria de Alcoy, Carlos Del Pozo Fernández, Carlos Del Pozo-Fernández, Carlos Pardo Ruíz, Carlos Pardo-Ruiz, Concepción Sánchez Botella, Concepción Sánchez-Botella, Vanesa Blanes Castañer, Vanesa Blanes-Castañer, Ramón López-Menchero, Cristina Gisbert Sellés, Cristina Gisbert-Sellés, Carmen Sánchez Jodar, Carmen Sánchez-Jodar, Luis Álvarez Avellan, Luis Álvarez-Avellán
10.3265/Nefrologia.pre2012.Jan.11244
Nefrologia (English Version) 2012;32:367-73
Recommendations for the pharmacologic treatment of hyperglycemia in type 2 diabetes. Consensus document
Menéndez Torre, Lafita Tejedor, Artola Menéndez, Milán Núñez-Cortés, Alonso García, Puig Domingo, García Solans, Álvarez Guisasola, García Alegría, Mediavilla Bravo, Miranda Fernández-Santos, Romero González
10.3265/Nefrologia.pre2010.Nov.10715
Nefrologia (English Version) 2011;31:17-26
Type 2 sodium-glucose cotransporter (SGLT2) inhibitors: from familial renal glucosuria to the treatment of type 2 diabetes mellitus
Pérez López, González Albarrán, Cano Megías
10.3265/Nefrologia.pre2010.Sep.10494
Nefrologia (English Version) 2010;30:618-25
Prevalence of chronic kidney disease in type 2 diabetes patients in primary care
Grupo de Investigación ERC Aragón, Lou Arnal, Campos Gutiérrez, Cuberes Izquierdo, Gracia García, Turón Alcaine, Bielsa Gracia, Gimeno Orna, Boned Juliani, Sanjuán Hernández-French
10.3265/Nefrologia.pre2010.Jun.10260
Nefrologia (English Version) 2010;30:552-6
Patients on peritoneal dialysis with type 2 diabetes have poorer outcomes than non-diabetics due to preceding cardiovascular comorbidity
miembros del GCDP, José Portolés, Elena Corchete, Paula López-Sánchez, Francisco Coronel, Javier Ocaña, Alberto Ortiz
10.3265/Nefrologia.2009.29.4.5383.en.full
Nefrologia (English Version) 2009;29:336-42
Is CERA therapy every 2-4 weeks worse than usual EPO therapy 1-3 times per week?
R. Saracho Rotaeche
Nefrologia (English Version) 2008;28 Supl 2:28-9
Can blood pressure control independently reduce the risk for developing microalbuminuria in type 2 Diabetes patients without diabetic nephropathy?
A. Martínez-Castelao, J. L. Górriz, C. Quereda
Nefrologia (English Version) 2007;27 Supl 5:16-7
Open access
This work is licensed under a Creative Commons Attribution 4.0 International License.
Publish in
Nefrología
NEFROLOGÍA
AL DÍA
AL DÍA
